Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Psoriasis and beta-blockade].

V Steinkraus1, H Mensing

  • 1Hautklinik Universitäts-Krankenhaus Hamburg-Eppendorf.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|April 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies.

The British journal of dermatology·2015
Same author

[Cutaneous granulomatous reactions at botulinum neurotoxin A injection sites: First manifestation of systemic sarcoidosis].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2015
Same author

Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.

The British journal of dermatology·2012
Same author

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.

The British journal of dermatology·2011
Same author

Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data.

The British journal of dermatology·2009
Same author

[Does dilution have an impact on cosmetic results with BoNT/A? Complex-protein-free BoNT/A for treatment of glabella lines].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2009
Same journal

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral infections of the skin].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral exanthems in children].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Erratum to: Digital health applications and data protection].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Virus-induced exanthems in returning travellers].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Venous ulcus cruris-Surgical treatment].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
See all related articles

Beta-adrenergic blocking drugs can cause psoriasiform skin eruptions. Blocking beta-adrenergic receptors on keratinocytes may be the key cause of this side effect.

Area of Science:

  • Dermatology
  • Pharmacology

Context:

  • Beta-adrenergic blocking drugs are widely used for various cardiovascular conditions.
  • Psoriasiform skin eruptions are an increasingly recognized adverse effect associated with these drugs.

Purpose:

  • To review the current understanding of psoriasiform skin eruptions linked to beta-adrenergic blocking drugs.
  • To discuss the clinical presentation, pharmacology, and potential pathogenesis of this side effect.

Summary:

  • Psoriasiform skin eruptions are a notable side effect of beta-adrenergic blocking drugs.
  • The pathogenesis may involve the blockade of beta-adrenergic receptors on keratinocytes.
  • This review synthesizes current knowledge and experimental data on this phenomenon.

Impact:

Related Experiment Videos

  • Provides clinicians with updated information on managing this adverse drug reaction.
  • Highlights the potential role of keratinocyte beta-adrenergic receptors in drug-induced skin conditions.
  • Informs public health agencies regarding drug safety communications.